Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1586

1.

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.

Cohen JA, Comi G, Selmaj KW, Bar-Or A, Arnold DL, Steinman L, Hartung HP, Montalban X, Kubala Havrdová E, Cree BAC, Sheffield JK, Minton N, Raghupathi K, Huang V, Kappos L; RADIANCE Trial Investigators.

Lancet Neurol. 2019 Sep 3. pii: S1474-4422(19)30238-8. doi: 10.1016/S1474-4422(19)30238-8. [Epub ahead of print]

PMID:
31492652
2.

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.

Comi G, Kappos L, Selmaj KW, Bar-Or A, Arnold DL, Steinman L, Hartung HP, Montalban X, Kubala Havrdová E, Cree BAC, Sheffield JK, Minton N, Raghupathi K, Ding N, Cohen JA; SUNBEAM Study Investigators.

Lancet Neurol. 2019 Sep 3. pii: S1474-4422(19)30239-X. doi: 10.1016/S1474-4422(19)30239-X. [Epub ahead of print]

PMID:
31492651
3.

Novel mutations in DNA2 associated with myopathy and mtDNA instability.

Ronchi D, Liu C, Caporali L, Piga D, Li H, Tagliavini F, Valentino ML, Ferrò MT, Bini P, Zheng L, Carelli V, Shen B, Comi GP.

Ann Clin Transl Neurol. 2019 Sep 2. doi: 10.1002/acn3.50888. [Epub ahead of print]

4.

Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy.

Peretto G, Di Resta C, Perversi J, Forleo C, Maggi L, Politano L, Barison A, Previtali SC, Carboni N, Brun F, Pegoraro E, D'Amico A, Rodolico C, Magri F, Manzi RC, Palladino A, Isola F, Gigli L, Mongini TE, Semplicini C, Calore C, Ricci G, Comi GP, Ruggiero L, Bertini E, Bonomo P, Nigro G, Resta N, Emdin M, Favale S, Siciliano G, Santoro L, Sinagra G, Limongelli G, Ambrosi A, Ferrari M, Golzio PG, Bella PD, Benedetti S, Sala S; Italian Network for Laminopathies (NIL).

Ann Intern Med. 2019 Sep 3. doi: 10.7326/M18-2768. [Epub ahead of print]

PMID:
31476771
5.

Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis.

Acquaviva M, Bassani C, Sarno N, Dalla Costa G, Romeo M, Sangalli F, Colombo B, Moiola L, Martinelli V, Comi G, Farina C.

Front Immunol. 2019 Aug 14;10:1922. doi: 10.3389/fimmu.2019.01922. eCollection 2019.

6.

Ophthalmoplegia Due to Miller Fisher Syndrome in a Patient With Myasthenia Gravis.

Brusa R, Faravelli I, Gagliardi D, Magri F, Cogiamanian F, Saccomanno D, Cinnante C, Mauri E, Abati E, Bresolin N, Corti S, Comi GP.

Front Neurol. 2019 Aug 13;10:823. doi: 10.3389/fneur.2019.00823. eCollection 2019.

7.

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Ghezzi A, Comi G, Grimaldi LM, Moiola L, Pozzilli C, Fantaccini S, Gallo P.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5). pii: e591. doi: 10.1212/NXI.0000000000000591. Print 2019 Sep.

8.

Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis.

Preziosa P, Rocca MA, Riccitelli GC, Moiola L, Storelli L, Rodegher M, Comi G, Signori A, Falini A, Filippi M.

Neurotherapeutics. 2019 Aug 26. doi: 10.1007/s13311-019-00781-w. [Epub ahead of print]

PMID:
31452082
9.

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.

Gagliardi D, Meneri M, Saccomanno D, Bresolin N, Comi GP, Corti S.

Int J Mol Sci. 2019 Aug 25;20(17). pii: E4152. doi: 10.3390/ijms20174152. Review.

10.

CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1.

Forotti G, Nizzardo M, Bucchia M, Ramirez A, Trombetta E, Gatti S, Bresolin N, Comi GP, Corti S.

Exp Neurol. 2019 Nov;321:113041. doi: 10.1016/j.expneurol.2019.113041. Epub 2019 Aug 21.

PMID:
31445043
11.

Emotional outcomes in clinically isolated syndrome and early phase multiple sclerosis: a systematic review and meta-analysis.

Rintala A, Matcham F, Radaelli M, Locafaro G, Simblett S, Barattieri di San Pietro C, Bulgari V, Burke P, Devonshire J, Weyer J, Wykes T, Comi G, Hotopf M, Myin-Germeys I; on the behalf of the RADAR-CNS Consortium.

J Psychosom Res. 2019 Sep;124:109761. doi: 10.1016/j.jpsychores.2019.109761. Epub 2019 Jul 5. Review.

PMID:
31443806
12.

Limitations in daily activities and general perception of quality of life: Long term follow-up in patients with anti-myelin-glycoprotein antibody polyneuropathy.

Campagnolo M, Ruiz M, Falzone YM, Ermani M, Bianco M, Martinelli D, Cerri F, Quattrini A, Salvalaggio A, Castellani F, Comi G, Giannini F, Nobile-Orazio E, Fazio R, Riva N, Briani C.

J Peripher Nerv Syst. 2019 Sep;24(3):276-282. doi: 10.1111/jns.12342. Epub 2019 Aug 26.

PMID:
31397934
13.

Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.

Pisa M, Ratti F, Vabanesi M, Radaelli M, Guerrieri S, Moiola L, Martinelli V, Comi G, Leocani L.

Mult Scler. 2019 Aug 8:1352458519861603. doi: 10.1177/1352458519861603. [Epub ahead of print]

PMID:
31392924
14.

Activity evaluation of pure and doped zinc oxide nanoparticles against bacterial pathogens and Saccharomyces cerevisiae.

Zanet V, Vidic J, Auger S, Vizzini P, Lippe G, Iacumin L, Comi G, Manzano M.

J Appl Microbiol. 2019 Aug 6. doi: 10.1111/jam.14407. [Epub ahead of print]

PMID:
31386785
15.

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.

Brogna C, Coratt G, Pane M, Ricotti V, Messina S, D'Amico A, Bruno C, Vita G, Berardinelli A, Mazzone E, Magri F, Ricci F, Mongini T, Battini R, Bello L, Pegoraro E, Baranello G, Previtali SC, Politano L, Comi GP, Sansone VA, Donati A, Bertini E, Muntoni F, Goemans N, Mercuri E; on behalf on the International DMD group.

PLoS One. 2019 Jul 31;14(7):e0220714. doi: 10.1371/journal.pone.0220714. eCollection 2019.

16.

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Ghezzi A, Comi G, Grimaldi LM, Moiola L, Pozzilli C, Fantaccini S, Gallo P.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e591. doi: 10.1212/NXI.0000000000000591. eCollection 2019 Sep.

17.

The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "in Vivo" in the Differential Diagnosis of Alzheimer's Dementia.

Santangelo R, Dell Edera A, Sala A, Cecchetti G, Masserini F, Caso F, Pinto P, Leocani L, Falautano M, Passerini G, Martinelli V, Comi G, Perani D, Magnani G.

Curr Alzheimer Res. 2019 Jul 25. doi: 10.2174/1567205016666190725150836. [Epub ahead of print]

PMID:
31345148
18.

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.

Vabanesi M, Pisa M, Guerrieri S, Moiola L, Radaelli M, Medaglini S, Martinelli V, Comi G, Leocani L.

Sci Rep. 2019 Jul 17;9(1):10371. doi: 10.1038/s41598-019-46251-3.

19.

Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein.

Castoldi V, Marenna S, d'Isa R, Huang SC, De Battista D, Chirizzi C, Chaabane L, Kumar D, Boschert U, Comi G, Leocani L.

Brain Pathol. 2019 Jul 3. doi: 10.1111/bpa.12762. [Epub ahead of print]

PMID:
31267597
20.

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.

Brogna C, Coratti G, Pane M, Ricotti V, Messina S, D'Amico A, Bruno C, Vita G, Berardinelli A, Mazzone E, Magri F, Ricci F, Mongini T, Battini R, Bello L, Pegoraro E, Baranello G, Previtali SC, Politano L, Comi GP, Sansone VA, Donati A, Bertini E, Muntoni F, Goemans N, Mercuri E; on behalf on the International DMD group.

PLoS One. 2019 Jun 25;14(6):e0218683. doi: 10.1371/journal.pone.0218683. eCollection 2019. Erratum in: PLoS One. 2019 Jul 31;14(7):e0220714.

21.

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428. [Epub ahead of print]

PMID:
31221001
22.

Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★.

Miller AE, Vermersch P, Kappos L, Comi G, Freedman MS, Oh J, de Seze J, Truffinet P, Benamor M, Purvis A, Wolinsky JS; TOPIC study group.

Mult Scler Relat Disord. 2019 Aug;33:131-138. doi: 10.1016/j.msard.2019.05.014. Epub 2019 May 24.

23.

Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy".

Dalla Costa G, Martinelli V, Furlan R, Comi G.

Ann Neurol. 2019 Aug;86(2):324. doi: 10.1002/ana.25526. Epub 2019 Jun 26. No abstract available.

PMID:
31187511
24.

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials.

Comi G, Miller AE, Benamor M, Truffinet P, Poole EM, Freedman MS.

Mult Scler. 2019 Jun 7:1352458519851981. doi: 10.1177/1352458519851981. [Epub ahead of print]

PMID:
31172849
25.

Expanding the spectrum of genes responsible for hereditary motor neuropathies.

Previtali SC, Zhao E, Lazarevic D, Pipitone GB, Fabrizi GM, Manganelli F, Mazzeo A, Pareyson D, Schenone A, Taroni F, Vita G, Bellone E, Ferrarini M, Garibaldi M, Magri S, Padua L, Pennisi E, Pisciotta C, Riva N, Scaioli V, Scarlato M, Tozza S, Geroldi A, Jordanova A, Ferrari M, Molineris I, Reilly MM, Comi G, Carrera P, Devoto M, Bolino A.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1171-1179. doi: 10.1136/jnnp-2019-320717. Epub 2019 Jun 5.

PMID:
31167812
26.

Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis.

Dalla Costa G, Romeo M, Esposito F, Sangalli F, Colombo B, Radaelli M, Moiola L, Comi G, Martinelli V.

Mult Scler Relat Disord. 2019 Aug;33:75-77. doi: 10.1016/j.msard.2019.05.010. Epub 2019 May 21.

PMID:
31158806
27.

Prospects for the Use of Whey for Polyhydroxyalkanoate (PHA) Production.

Amaro TMMM, Rosa D, Comi G, Iacumin L.

Front Microbiol. 2019 May 9;10:992. doi: 10.3389/fmicb.2019.00992. eCollection 2019. Review.

28.

Engaging across dimensions of diversity: A cross-national perspective on mHealth tools for managing relapsing remitting and progressive multiple sclerosis.

Simblett SK, Evans J, Greer B, Curtis H, Matcham F, Radaelli M, Mulero P, Arévalo MJ, Polhemus A, Ferrao J, Gamble P, Comi G, Wykes T; RADAR-CNS consortium.

Mult Scler Relat Disord. 2019 Jul;32:123-132. doi: 10.1016/j.msard.2019.04.020. Epub 2019 Apr 16.

PMID:
31125754
29.

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies.

Piga D, Salani S, Magri F, Brusa R, Mauri E, Comi GP, Bresolin N, Corti S.

Ther Adv Neurol Disord. 2019 May 3;12:1756286419833478. doi: 10.1177/1756286419833478. eCollection 2019. Review.

30.

Microbial quality of raw and ready-to-eat mung bean sprouts produced in Italy.

Iacumin L, Comi G.

Food Microbiol. 2019 Sep;82:371-377. doi: 10.1016/j.fm.2019.03.014. Epub 2019 Mar 15.

PMID:
31027796
31.

Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72.

Falzone YM, Radaelli M, Agosta F, Domi T, Guerrieri S, Spinelli EG, Pozzi L, Carrera P, Ferrari M, Comi G, Filippi M, Quattrini A, Riva N.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):449-452. doi: 10.1080/21678421.2019.1604761. Epub 2019 Apr 22.

PMID:
31007077
32.

Survival prediction models in motor neuron disease.

Agosta F, Spinelli EG, Riva N, Fontana A, Basaia S, Canu E, Castelnovo V, Falzone Y, Carrera P, Comi G, Filippi M.

Eur J Neurol. 2019 Sep;26(9):1143-1152. doi: 10.1111/ene.13957. Epub 2019 Apr 20.

PMID:
30920076
33.

Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.

Abati E, Bresolin N, Comi G, Corti S.

Mol Neurobiol. 2019 Oct;56(10):6703-6715. doi: 10.1007/s12035-019-1554-x. Epub 2019 Mar 26. Review.

PMID:
30911936
34.

Multispectral MRI with Dual Fluorinated Probes to Track Mononuclear Cell Activity in Mice.

Chirizzi C, De Battista D, Tirotta I, Metrangolo P, Comi G, Bombelli FB, Chaabane L.

Radiology. 2019 May;291(2):351-357. doi: 10.1148/radiol.2019181073. Epub 2019 Mar 19.

PMID:
30888930
35.

Thrombus hallmarks reveal atherothrombotic stroke aetiology.

Semerano A, Genchi A, Callea M, Sanvito F, Simionato F, Panni P, Scomazzoni F, Doglioni C, Comi G, Falini A, Filippi M, Roveri L, Bacigaluppi M.

J Neurol. 2019 Jun;266(6):1533-1535. doi: 10.1007/s00415-019-09279-z. Epub 2019 Mar 19. No abstract available.

PMID:
30888500
36.

Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis.

Comi G, Cook S, Giovannoni G, Rieckmann P, Sørensen PS, Vermersch P, Galazka A, Nolting A, Hicking C, Dangond F.

Mult Scler Relat Disord. 2019 Apr;29:168-174. doi: 10.1016/j.msard.2019.01.038. Epub 2019 Jan 24.

37.

Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.

Cook S, Leist T, Comi G, Montalban X, Giovannoni G, Nolting A, Hicking C, Galazka A, Sylvester E.

Mult Scler Relat Disord. 2019 Apr;29:157-167. doi: 10.1016/j.msard.2018.11.021. Epub 2018 Nov 20.

38.

Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients.

Musumeci O, Barca E, Lamperti C, Servidei S, Comi GP, Moggio M, Mongini T, Siciliano G, Filosto M, Pegoraro E, Primiano G, Ronchi D, Vercelli L, Orsucci D, Bello L, Zeviani M, Mancuso M, Toscano A.

Front Neurol. 2019 Feb 27;10:160. doi: 10.3389/fneur.2019.00160. eCollection 2019.

39.

Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy.

Monfrini E, Straniero L, Bonato S, Monzio Compagnoni G, Bordoni A, Dilena R, Rinchetti P, Silipigni R, Ronchi D, Corti S, Comi GP, Bresolin N, Duga S, Di Fonzo A.

Parkinsonism Relat Disord. 2019 Jun;63:66-72. doi: 10.1016/j.parkreldis.2019.02.045. Epub 2019 Mar 1.

PMID:
30850329
40.

Semi-invasive and non-invasive recording of visual evoked potentials in mice.

Marenna S, Castoldi V, d'Isa R, Marco C, Comi G, Leocani L.

Doc Ophthalmol. 2019 Jun;138(3):169-179. doi: 10.1007/s10633-019-09680-z. Epub 2019 Mar 6.

PMID:
30840173
41.

Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art.

Barbullushi K, Abati E, Rizzo F, Bresolin N, Comi GP, Corti S.

Mol Neurobiol. 2019 Sep;56(9):6460-6471. doi: 10.1007/s12035-019-1533-2. Epub 2019 Mar 4. Review.

PMID:
30830587
42.

Correction to: The Italian multiple sclerosis register.

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group.

Neurol Sci. 2019 Apr;40(4):907. doi: 10.1007/s10072-019-03772-z.

PMID:
30815752
43.

Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature.

Gagliardi D, Mauri E, Magri F, Velardo D, Meneri M, Abati E, Brusa R, Faravelli I, Piga D, Ronchi D, Triulzi F, Peverelli L, Sciacco M, Bresolin N, Comi GP, Corti S, Govoni A.

Front Neurol. 2019 Jan 31;10:38. doi: 10.3389/fneur.2019.00038. eCollection 2019.

44.

Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data.

Giordano A, Vabanesi M, Dalla Costa G, Cerri F, Comi G, Martinelli V, Fazio R.

Neurol Sci. 2019 May;40(5):1015-1018. doi: 10.1007/s10072-019-03757-y. Epub 2019 Feb 14.

PMID:
30762168
45.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G.

Ann Neurol. 2019 Apr;85(4):606-610. doi: 10.1002/ana.25437. Epub 2019 Mar 5.

PMID:
30761586
46.

Muscle pain in mitochondrial diseases: a picture from the Italian network.

Filosto M, Cotti Piccinelli S, Lamperti C, Mongini T, Servidei S, Musumeci O, Tonin P, Santorelli FM, Simoncini C, Primiano G, Vercelli L, Rubegni A, Galvagni A, Moggio M, Comi GP, Carelli V, Toscano A, Padovani A, Siciliano G, Mancuso M.

J Neurol. 2019 Apr;266(4):953-959. doi: 10.1007/s00415-019-09219-x. Epub 2019 Feb 2.

PMID:
30710167
47.

Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study.

Cordani C, Meani A, Esposito F, Valsasina P, Colombo B, Pagani E, Preziosa P, Comi G, Filippi M, Rocca MA.

Mult Scler. 2019 Jan 18:1352458518822145. doi: 10.1177/1352458518822145. [Epub ahead of print]

PMID:
30657011
48.

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons.

Rizzo F, Nizzardo M, Vashisht S, Molteni E, Melzi V, Taiana M, Salani S, Santonicola P, Di Schiavi E, Bucchia M, Bordoni A, Faravelli I, Bresolin N, Comi GP, Pozzoli U, Corti S.

Brain. 2019 Feb 1;142(2):276-294. doi: 10.1093/brain/awy330. Erratum in: Brain. 2019 May 1;142(5):e20.

49.

Brain and cord imaging features in neuromyelitis optica spectrum disorders.

Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, Pagani E, Martinelli V, Matthews L, Drulovic J, Leite MI, Comi G, Filippi M, Rocca MA.

Ann Neurol. 2019 Mar;85(3):371-384. doi: 10.1002/ana.25411. Epub 2019 Jan 28.

PMID:
30635936
50.

Functional and morphological changes of the retinal vessels in Alzheimer's disease and mild cognitive impairment.

Querques G, Borrelli E, Sacconi R, De Vitis L, Leocani L, Santangelo R, Magnani G, Comi G, Bandello F.

Sci Rep. 2019 Jan 11;9(1):63. doi: 10.1038/s41598-018-37271-6.

Supplemental Content

Support Center